Abstract:Artificial Intelligence–Assisted Prediction of Neonatal Sepsis:
Advancing Infection Control Strategies in the NICU
Background:
Neonatal sepsis continues to be a major cause of neonatal morbidity and mortality worldwide,
particularly in resource-limited healthcare settings. Early diagnosis remains challenging due to
non-specific clinical presentations and the limited sensitivity of conventional diagnostic markers
during the initial stages of infection. Delays in recognition can contribute to increased mortality
and facilitate transmission of pathogens within neonatal intensive care units (NICUs). Recent
advances in Artificial Intelligence and Machine Learning have enabled the development of
predictive models capable of analyzing complex clinical datasets and identifying early risk
patterns associated with neonatal infections.
Methods:
This study performed a predictive framework using machine learning algorithms to identify
early indicators of neonatal sepsis and support infection control measures in NICUs.
Retrospective clinical and laboratory datasets were integrated, including maternal risk factors,
neonatal physiological parameters, hematological indices, inflammatory biomarkers,
antimicrobial exposure, and environmental infection control variables. Supervised learning
techniques such as random forest, gradient boosting, and neural network models will be
applied to detect patterns associated with early-onset and late-onset neonatal sepsis. The
developed predictive model will generate risk scores that can be incorporated into clinical
decision-support systems to alert clinicians and infection control teams in real time.
Results:
AI-assisted predictive modeling is expected to enhance early risk stratification for neonatal
sepsis compared with conventional clinical assessment methods. The system may enable earlier
identification of high-risk neonates, facilitate timely diagnostic testing, and support targeted
infection control interventions within NICUs. Integration of predictive analytics with hospital
surveillance systems could improve outbreak detection, optimize antibiotic stewardship, and
reduce nosocomial transmission.
Conclusion:
Artificial intelligence–driven prediction models offer significant potential to strengthen
infection surveillance and prevention strategies in neonatal care. By integrating clinical data
with infection control monitoring, these systems can enable earlier intervention, reduce
diagnostic delays, and improve neonatal outcomes. Future prospective multicenter validation
studies will be essential to establish the clinical utility and scalability of AI-assisted neonatal
sepsis prediction models.
